Related Experiment Videos
Continuous nebulization: a treatment modality for pediatric asthma patients
Pediatric Nursing
|July 1, 1995
Summary
Continuous Beta 2 agonist nebulization is a safe and effective treatment for severe pediatric asthma. This approach helps reduce emergency department visits and hospital admissions for children with acute asthma episodes.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Critical Care Nursing
Background:
- Asthma is a leading chronic respiratory disease in children, frequently causing emergency department visits and hospitalizations.
- Severe pediatric asthma exacerbations pose significant clinical challenges.
- Continuous nebulization of Beta 2 agonists is emerging as a therapeutic option.
Purpose of the Study:
- To investigate the safety and efficacy of continuous nebulization of Beta 2 agonists for pediatric patients with severe asthma.
- To evaluate the role of a multidisciplinary team in implementing this therapy.
- To prepare pediatric nurses for managing continuous nebulization in acute asthma care.
Main Methods:
- A multidisciplinary team at an urban northeastern hospital implemented continuous nebulization of Beta 2 agonists.
- The study focused on pediatric patients experiencing acute asthma episodes.
- Key aspects included equipment, monitoring, and nursing implications.
Main Results:
- Continuous administration of Beta-adrenergic agents was found to be safe and effective for pediatric patients with severe asthma.
- This therapeutic approach can be beneficial in managing acute asthma exacerbations.
- Understanding nursing implications is crucial for successful implementation.
Conclusions:
- Continuous nebulization of Beta 2 agonists is a viable and effective treatment strategy for severe pediatric asthma.
- Effective management requires a multidisciplinary approach and well-prepared nursing staff.
- This method holds promise for improving outcomes in pediatric asthma care.